iSAM Funds (UK)’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-10,337
Closed -$2.53M 352
2026
Q1
$2.53M Buy
+10,337
New +$2.41M 1.25% 8
2025
Q4
Sell
-26,214
Closed -$4.86M 505
2025
Q3
$4.86M Buy
26,214
+1,201
+5% +$206K 1% 3
2025
Q2
$3.82M Buy
25,013
+20,655
+474% +$3.17M 0.84% 12
2025
Q1
$723K Buy
4,358
+2,171
+99% +$340K 0.36% 92
2024
Q4
$316K Sell
2,187
-5,716
-72% -$886K 0.24% 172
2024
Q3
$1.28M Buy
+7,903
New +$1.26M 0.73% 30
2024
Q1
Sell
-12,768
Closed -$2M 298
2023
Q4
$2M Buy
+12,768
New +$1.96M 1.43% 2
2023
Q3
Sell
-5,229
Closed -$866K 287
2023
Q2
$866K Buy
+5,229
New +$844K 0.77% 37

Other funds holding JNJ

iSAM Funds (UK)'s JNJ Position: Q2 2026 in Review

iSAM Funds (UK) sold out of Johnson & Johnson (JNJ) in Q2 2026, closing a stake of 10,337 shares — an estimated $2.53M sold.

iSAM Funds (UK) first reported a position in JNJ in Q2 2023 and held it in 8 quarters. The position peaked at $4.86M in Q3 2025. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • iSAM Funds (UK) reported no remaining Johnson & Johnson position as of Q2 2026 after selling out during the quarter.
  • iSAM Funds (UK) sold 10,337 Johnson & Johnson shares in Q2 2026, an estimated $2.53M.
  • iSAM Funds (UK) first reported a position in Johnson & Johnson in Q2 2023 and held it in 8 quarters.
  • iSAM Funds (UK)'s Johnson & Johnson position peaked at $4.86M in Q3 2025.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on iSAM Funds (UK)'s 13F filing for Q2 2026, filed 12 Aug 2026.